Nureca Ltd. · NSE:NURECA
Nureca — Q3 FY2026 Earnings Presentation
27 slides from Nureca's earnings presentation, Jan 17, 2026
Slide 1: Investor Presentation (Q3 FY26) cover letter to stock exchanges
NURECA www.nureca.com Dated - 17.01.2026 BSE LIMITED NATIONAL STOCK EXCHANGE OF INDIA Corporate Relations Department LIMITED Phiroze Jeejeebhoy Towers Listing Department Dalal Street, Fort Exchange Plaza, 5% Floor, Plot no. C/1 Mumbai-400001 G Block, Bandra Kurla Complex, Bandra (E) Scrip code: 5432
Slide 2: Investor Presentation Q3 FY'26
NURECA Investor Presentation Q3 FY'26 Trust What's Best For Your Health
Slide 3: Disclaimer
NURECA Disclaimer The Presentation is to provide the general background information about the Company’s activities as at the date of the Presentation. The information contained herein is for general information purposes only and based on estimates and should not be considered as a recommendation tha
Slide 4: Our Vision and Mission
NURECA Our Vision To be a global leader in healthcare innovation, empowering individuals to take control of their well-being through cutting-edge technology, accessible solutions, and an unwavering commitment to excellence in quality and service. our Mission To provide world-class healthcare solutio
Slide 5: Table of Contents
Table of Contents Highlights of Q3 & FY 26 Business Highlights Business Performance - Q3 & 9M 26 Industry Landscape Growth Drivers
Slide 6: Financial Performance
NURECA We are a Digital First Healthcare Company with more than 90% revenue generated by Online sales Nureca is a debt-free, asset light company and has a healthy liquidity position. Financial Performance Revenue from Operations EBITDA Profit After Tax e Q3FY 26 - INR540 Mn e Q3FY26-INR396 Mn e Q3FY
Slide 7: Business Highlights
Business Highlights
Slide 8: 3P Interplay Generating Business MOAT
3P Interplay Generating Business MOAT (3P -Product - Placement — Promotion) Internal Strengths Curated Over the Years Across Product Design, Supply Chain, Distribution and Marketing is Onerous to Replicate Sustained focus on Innovation and Quality Products M Integrated Manufacturing Ecosystem J - 2
Slide 9: Strategic Pillars
Strategic Pillars D2C growth Omnipresence Manufacturing Connected Health Expand our already strong Establish pan India sales Building a strong manufacturing Transform lives of our users presence online by network with expansive reach base in India with focus on quality, through our Connected innovat
Slide 10: D2C growth
NURECA l. D2C growth Our growing digital customer base Our customer base has grown exceptionally over the last 5 years which is a result of remarkable quality of our o 90% £2 products that led to word-of-mouth marketing by our loyal customer base. Currently, our products have more Revenue Contributi
Slide 11: Diving into Our Products Portfolio
NURECA Diving into Our Products Portfolio Massagers Manipol Supervolt Go Gun Dynamo Rechargeable Gun Foot, Leg and Calf ~ TENStar Tens Massager Neck and Shoulder Weighing & Kitchen Scales -~ © | 8 Electrode smart Legend Smart Scale Hercules Scale Unbeatable Scale Electronic Kitchen Scale Kitchen Sca
Slide 12: Product Portfolio: Orthopedic, Baby Care, Respiratory
, I ' Orthopedic | I i ' Range-1 ' ' i ‘ Leg Elevation Maternity Backrest Neck Pillow for ' \ Coccyx Pillow Knee Pillow Backrest Pillow Wedge Pillow Support Pillow Wedge Pillow travelling Orthopedic T Range-1I Neck rest Car Neck Stretcher Heating Pads Memory> Memory Foam m Foam Pillow Cervical Pillo
Slide 13: New Launches
NURECA New Launches e e, ’ TRAVEL & WELLNESS SUPPORT ORTHOPEDIC & PAIN RELIEF "] . - é Cocoon Travel Pillow R Contoured Cervical Pillow Cervical Pillow Coccyx Cushion Seat
Slide 14: Manufacturing
Il. Manufacturing Our wholly owned manufacturing subsidiary Nureca Technologies Pvt Limited , stared operations in Apr'22. USFDA Registration No.: 3036779619 Products categories manufactured at NTPL: Blood Pressure Monitors Nebulizers N Electric Massagers w Oral and Infrared Thermometers M Heating P
Slide 15: Omnipresence
NURECA lll. Omnipresence Expanding Offline Distribution Over the years, our brand, Dr Trust, has garnered substantial recognition and commendation across e-commerce platforms. By capitalizing on this positive momentum, we anticipate a notable upswing in our retail trade network. We are in the proces
Slide 16: Connected Health
NUREgA Good evening ritu v DrTrust Smart K IV. Connected Health Dr Trust 360 is not just an app, it's a comprehensive health management companion that empowers users to take control Quick Measure . ® of their health through technology. < Body Composit Weight Kitchen A Weight By connecting trusted Dr
Slide 17: Dr Trust 360 Freemium Connected Health app
DrTrust 366 Freemium Connected Health app Our unified app is a Freemium model, where users are able to subscribe for Pro features like Advanced health reports, curated diet plans, calorie & water intake tracking, family & caregiver alerts on Whatsapp F F t Allows Users to access basic features at no
Slide 18: Rewards & Recognition
NURECA Rewards & Recognition > Dr Trust, Nureca’s flagship brand, has been ranked by customers as India’'s number one brand in the category of Home Healthcare and Wellness. > Dr Trust awarded in Best Healthcare Brands 2021 by Economic Times, Premium Prestigious Brands 2020 by Economic Times and in M
Slide 19: W \TT]
it W s A o r |\ e a \TT] I A 1144y | e | 9 B ; —— I D [ R S %‘ I“ ) ‘! \ ' — , j - I'l~
Slide 20: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) . EPS (¥ Revenue from Operations( ¥ Crore) ( )62 255.5 . I - (- = -8.3 -1.8 20-21 21-22 22-23 23-24 24-25 25-26 (3M) 20!21 21!22 22!23 23'»2A 2‘!25 25-28' ) Fixed Asset (¥Crore) 14.0 PAT ( Z Crore) 46.4 45.0 9.0 7.4 8.2 0.9 - | 1.8 -8.3 1 | 1 1 | 1 20
Slide 21: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) ROCE 2.3 Working Capital Turnover 23 Working Capital Turnover 67% 1.4 1.4 6% 1% 3 06 o5 06 0.6 % @5 W& 06 -— _— o i . . . . . 2021 2022 2023 2024 2025 9M 2026 2021 2022 2023 2024 2025 9M 2026 2021 2022 2023 2024 2025 9M 2026 PAT % Return on Equity 2%
Slide 22: Key Performance Indicators (Consolidated)
NURECA Key Performance Indicators (Consolidated) Current Ratio Debtor Turnover Ratio (Days) 20.9 20.8 16.8 15.3 1 12 12 8 I9.6 ] 2021 2022 2023 2024 2025 9M 2026 ==. IIl 2021 2022 2023 2024 2025 9M 2026 Inventory Turnover Ratio Debt To Equity Ratio 0.02 0.02 0.02 I I I } 2021 2022 2023 2024 2025 9M
Slide 23: Industry Landscape
Slide 24: Market Size for HealthCare Products in India & Neighboring Countries
NURECA Market Size for HealthCare Products in India & Neighboring Countries, 2025-2030E (in Crore) Self Monitoring Glucose Devices CAGR 2025-2030E ¢ (9.9%) 0, 5203 M Digital and Infrared Thermometers B Humidifiers and Steamers Pulse Oximeters 1408 Nebulizers 1315 3559 I Weighing & Kitchen Scales* 32
Slide 25: Digitization of Sales Process has Generated a Virtuous Flywheel
NURECA Digitization of Sales Process has Generated a Virtuous Flywheel enabling Faster Speed to Market Product Design E Manufacturing Ecosystem =2 Distribution E Marketing Digitization Our Data Centric Approach allows us to : Improved Customer e leveraging Consumer InvestmentinD2C & Engagements Insi
Slide 26: Growth Drivers Going Forward
NURECA Growth Drivers Going Forward Boosting Quick Commerce Reach and Market Penetration Driving In-house Manufacturing with Cutting-edge DrTrust USA Quality Innovations Drive Market Growth with New Product Launches and thereby Increase value proposition to customers Drive Deeper Market Penetration
Slide 27: Thank You
NURECA Thank You Contact Us Investor Relations | D Trustusa Nishu Kansal \¥ investor@nureca.com OR THOPEDIC [ i3 . Address Website HEAT BELT (BLUE) B3 Office No. 101, Udyog Bhavan, Corporate: www.Nureca.com Sonawala Lane, Goregaon East, Ecom Store: www.drtrust.in Mumboai, Maharashtra - 400063